GL1X · GenesisL1 explorer

Research workbench

Ligand binding to farnesoid-X-receptor

Analyse Ligand binding to farnesoid-X-receptor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5Q0M
Type
protein
Length
233 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Bile acid receptor; Coactivator peptide src-1 HD3
UniProt
Q96RI1, A8K1V4
Ligands
9L1
Pockets
2 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 77% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABile acid receptorprotein22377% helix, 0% strandQ96RI1
BCoactivator peptide src-1 HD3protein1080% helix, 0% strandA8K1V4

Ligands and binding sites

  • 9L1 · 5-{[(3beta,5beta,14beta,17alpha)-3-hydroxy-24-oxocholan-24-yl]amino}benzene-1,3-dicarboxylic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14150.820.90389L1
21580.450.7623empty

Interfaces

1 interface between chains.

  • A–B · 577 Ų buried · 8 hydrogen bonds · protein-protein

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.